Roopa Dhatt

In response to Who does your solution serve, and what needs of theirs does it address?

The fourth piece of the solution seems focused on public engagement, but in terms of audience there isn't mention of the general public

Dr James Kinross

REDASA is a tool principally designed to support healthcare workers, policymakers and biomedical experts who need access to interpret data during infodemics. The application has therefore been weighted to the primary user. However, we believe that the fact-checking components of this methodology will have great benefit to the general public.

Our partners, such as AWS have a global reach and a public-facing business. The IHME specialise in communicating science with the public. The National Institute for Health and Care Excellence (NICE) provides national guidance and advice to improve health and social care. NICE is an executive non-departmental public body, sponsored by the Department of Health and Social Care. It, therefore, specialises in producing and presenting clinical evidence to the public.

Our strategy for engaging with the public has therefore been based on discussions with all of our expert partners, but also with patients who have directly informed the proposal design (Mr. Harry Hall). Patients and the public will be represented on our advisory board. As part of this work, we will perform semi-structured interviews and qualitative assessments of the technology to ensure that it is fit for its purpose and that it has maximum impact.

Through the proposed CURADR platform we will build a community, with a goal of 10,000 active members worldwide in the scope of the award timeline. We envisage that patients and members of the public will be able to directly engage with this process. However, we will also be able to distribute our learnings, outputs and fact-checking tools directly through our partner organisations who currently have direct access to the public.

to Top